Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Glaxosmithkline Pharmaceuticals Ltd
Industry : Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value(
)
500660
INE159A01016
98.8545682
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GLAXO
57.89
46075.05
EPS(TTM)
Face Value(
)
Div & Yield %:
46.98
10
1.18
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
3407.25
3216.34
3217.51
2920.48
3224.68
3128.53
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3407.25
3216.34
3217.51
2920.48
3224.68
3128.53
Other Income
143.17
114.96
1423.27
217.71
624.37
149.56
Stock Adjustments
69.64
-67.25
-13.83
26.12
35.43
-25.57
Total Income
3620.06
3264.05
4626.95
3164.31
3884.48
3252.52
EXPENDITURE :
Raw Materials
1358.07
1182.78
1281.91
1275.49
1343.30
1327.96
Power & Fuel Cost
29.64
29.60
27.83
26.08
33.36
27.94
Employee Cost
624.39
594.99
610.23
616.16
628.55
537.20
Other Manufacturing Expenses
113.61
99.05
120.14
110.59
107.88
115.19
Selling & Administrative Expenses
374.71
370.30
343.57
242.00
376.68
381.32
Miscellaneous Expenses
239.12
84.32
85.69
287.75
983.19
150.08
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2739.54
2361.04
2469.38
2558.07
3472.96
2539.68
Operating Profit
880.52
903.01
2157.57
606.24
411.52
712.85
Interest
1.80
1.81
1.99
3.53
6.34
0.55
Gross Profit
878.72
901.20
2155.58
602.71
405.18
712.30
Depreciation
69.68
65.77
68.19
78.60
82.68
48.59
Profit Before Tax
809.04
835.43
2087.39
524.11
322.50
663.71
Tax
235.71
246.05
407.36
158.67
260.17
192.82
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-11.36
-18.37
-10.49
7.87
-47.72
45.52
Reported Net Profit
584.69
607.75
1690.53
357.57
110.05
425.36
Extraordinary Items
-66.58
21.05
11.18
-117.79
-87.09
4.04
Adjusted Net Profit
651.27
586.70
1679.35
475.36
197.14
421.32
Adjustment below Net Profit
-21.25
-17.08
-11.05
0.00
-73.62
-64.12
P & L Balance brought forward
828.12
1745.02
562.71
882.77
1177.99
1113.21
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
542.10
1524.66
508.22
677.62
338.81
296.46
P & L Balance carried down
849.46
811.03
1733.98
562.71
875.62
1177.99
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
320.00
320.00
900.00
300.00
400.00
200.00
Dividend Per Share(Rs)
32.00
32.00
90.00
30.00
40.00
20.00
Earnings Per Share-Unit Curr
34.51
35.88
99.79
21.11
6.50
25.11
Earnings Per Share(Adj)-Unit Curr
34.51
35.88
99.79
21.11
6.50
25.11
Book Value-Unit Curr
105.31
103.48
158.06
88.37
108.62
126.47
Book Value(Adj)-Unit Curr
105.31
103.48
158.06
88.37
108.62
126.47